Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human Granzyme B Based Targeted Cytolytic Fusion Proteins.
Hlongwane P, Mungra N, Madheswaran S, Akinrinmade OA, Chetty S, Barth S. Hlongwane P, et al. Among authors: akinrinmade oa. Biomedicines. 2018 Jun 20;6(2):72. doi: 10.3390/biomedicines6020072. Biomedicines. 2018. PMID: 29925790 Free PMC article. Review.
Human MAP Tau Based Targeted Cytolytic Fusion Proteins.
Akinrinmade OA, Jordaan S, Hristodorov D, Mladenov R, Mungra N, Chetty S, Barth S. Akinrinmade OA, et al. Biomedicines. 2017 Jun 27;5(3):36. doi: 10.3390/biomedicines5030036. Biomedicines. 2017. PMID: 28653985 Free PMC article. Review.
A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate.
Daramola AK, Akinrinmade OA, Fajemisin EA, Naran K, Mthembu N, Hadebe S, Brombacher F, Huysamen AM, Fadeyi OE, Hunter R, Barth S. Daramola AK, et al. Among authors: akinrinmade oa. Immunother Adv. 2022 Dec 6;3(1):ltac023. doi: 10.1093/immadv/ltac023. eCollection 2023. Immunother Adv. 2022. PMID: 36789295 Free PMC article.
Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells.
Huysamen AM, Fadeyi OE, Mayuni G, Dogbey DM, Mungra N, Biteghe FAN, Hardcastle N, Ramamurthy D, Akinrinmade OA, Naran K, Cooper S, Lang D, Richter W, Hunter R, Barth S. Huysamen AM, et al. Among authors: akinrinmade oa. ACS Omega. 2023 Jan 17;8(4):4026-4037. doi: 10.1021/acsomega.2c06844. eCollection 2023 Jan 31. ACS Omega. 2023. PMID: 36743041 Free PMC article.